These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 8591891)

  • 1. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
    Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
    Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
    Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
    Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts.
    Mital S; Loke KE; Slater JP; Addonizio L; Gersony WM; Hintze TH
    Am J Cardiol; 1999 Jun; 83(12A):92H-98H. PubMed ID: 10750596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
    Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
    Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with ramiprilat induces cardioprotection against free radical injury in guinea-pig isolated heart: involvement of bradykinin, protein kinase C and prostaglandins.
    Jin ZQ; Chen X
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):257-62. PubMed ID: 10779122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.
    Hartman JC; Kurc GM; Hullinger TG; Wall TM; Sheehy RM; Shebuski RJ
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1071-6. PubMed ID: 7523655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric oxide and bradykinin in conductance and resistance arteries.
    Sudhir K; Chou TM; Hutchison SJ; Chatterjee K
    Circulation; 1996 May; 93(9):1734-9. PubMed ID: 8653880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
    Farhy RD; Carretero OA; Ho KL; Scicli AG
    Circ Res; 1993 Jun; 72(6):1202-10. PubMed ID: 7684331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
    Matoba S; Tatsumi T; Keira N; Kawahara A; Akashi K; Kobara M; Asayama J; Nakagawa M
    Circulation; 1999 Feb; 99(6):817-22. PubMed ID: 9989969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
    Rumble JR; Komers R; Cooper ME
    J Hypertens; 1996 May; 14(5):601-7. PubMed ID: 8762203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.
    Hartman JC; Hullinger TG; Wall TM; Shebuski RJ
    Eur J Pharmacol; 1993 Apr; 234(2-3):229-36. PubMed ID: 8482328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.
    Hartman JC; Wall TM; Hullinger TG; Shebuski RJ
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):996-1003. PubMed ID: 7687728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury.
    Node K; Kitakaze M; Kosaka H; Minamino T; Mori H; Hori M
    Hypertension; 1998 Jun; 31(6):1290-8. PubMed ID: 9622144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.
    Kawabata H; Ryomoto T; Ishikawa K
    Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
    Wang CH; Leung N; Lapointe N; Szeto L; Uffelman KD; Giacca A; Rouleau JL; Lewis GF
    Circulation; 2003 Apr; 107(14):1923-9. PubMed ID: 12668518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neutral endopeptidase 24.11 inhibition on myocardial ischemia/reperfusion injury: the role of kinins.
    Yang XP; Liu YH; Peterson E; Carretero OA
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):250-6. PubMed ID: 9057075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion.
    Brunner F; Kukovetz WR
    Circulation; 1996 Oct; 94(7):1752-61. PubMed ID: 8840871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of epinephrine-induced dysrhythmias by bradykinin: role of nitric oxide and prostaglandins.
    Rajani V; Hussain Y; Bolla BS; de Guzman FQ; Montiague RR; Igić R; Rabito SF
    Am J Cardiol; 1997 Aug; 80(3A):153A-157A. PubMed ID: 9293970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.